Natürliche Familienplanung

Frank‐Herrmann, Petra; Sottong, Ursula; Baur, Siegfried; Raith-Paula, Elisabeth; Strowitzki, T.; Freundl, Günter

doi:10.1007/s00129-010-2659-5

Cited by 17 publications

(3 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fertility awareness methods are based on daily basal body temperature measurements to detect the progesterone-induced postovulatory temperature shift. This symptothermal method uses a combination of morning basal body temperature measurements and assessment of the cervical mucus and has been thoroughly investigated in fertile and infertile couples [13,14].…”

Section: Introductionmentioning

confidence: 99%

Continuous Body Temperature Monitoring to Improve the Diagnosis of Female Infertility

Goeckenjan

Schiwek

Wimberger

2020

Geburtshilfe Frauenheilkd

View full text Add to dashboard Cite

Introduction Ovulatory dysfunction is a major cause of female infertility. We evaluated the use of continuous body temperature monitoring with a vaginal biosensor to improve standard diagnostic procedures for determining ovulatory dysfunction. Material and Methods This prospective interventional study was performed in a reproductive medicine department of a university hospital. The menstrual cycles of 51 women with infertility were monitored and analysed using three different strategies: sonographic and hormonal assessment (standard approach), continuous core body temperature measurement and analysis using the algorithm of OvulaRing, and lowest daily body temperature measurement monitored with a vaginal biosensor and analysed based on the body temperature curves used in natural family planning. Results Statistically significant differences were found in the temperature curves of women with luteal phase deficiency and polycystic ovary syndrome compared to women with normal menstrual cycles. The analysis of individual cyclofertilograms can be used to detect cycle phases and estimate the date of ovulation. Conclusions Continuous body temperature monitoring with a vaginal biosensor can improve the standard diagnostic procedures used to determine ovulatory dysfunction, especially if dysfunction is due to luteal phase deficiency and polycystic ovary syndrome. Analysis of the lowest daily body temperature combined with the basal body temperature measurements used in fertility awareness methods may be equieffective to continuous body temperature measurements with OvulaRing. The results of this study show that a revised diagnostic approach using fewer hormonal assessments combined with continuous body temperature monitoring can reduce the number of appointments in an infertility clinic as well as the costs.

show abstract

Section: Introductionmentioning

confidence: 99%

Continuous Body Temperature Monitoring to Improve the Diagnosis of Female Infertility

Goeckenjan

Schiwek

Wimberger

2020

Geburtshilfe Frauenheilkd

View full text Add to dashboard Cite

show abstract

“…We show results from data used in our study, “Prolongation of the Menstrual Cycle After Receipt of the Primary Series and Booster Doses of mRNA Coronavirus Disease 2019 (COVID-19) Vaccination,” 3 which limited cycles to those with ovulation date estimable from logged basal body temperature with the Sensiplan method. 4 We found that the prolongation of menstrual cycle length after vaccination during the follicular phase is a combination of a 2–3-day prolongation in the follicular phase and a 1–2-day shortening of luteal length (Table 1). Influence on follicular and luteal length in the next cycles were not observed.…”

mentioning

confidence: 85%

“…3 The time of maximum plasma concentration is the same for both, which is 3 hours, although the combination has a multiphasic concentration that lasts for up to 2 weeks or more. 4 In women in whom preterm labor is inevitable, the preferred drug of choice is one with quick onset of action, and prolonged steroid exposure is undesirable. We would like to reinforce that differences in population characteristics and management strategies are likely the major contributors to the differences in the outcome, rather than the composition of the drug.…”

Section: In Replymentioning

confidence: 99%